Literature DB >> 30259356

Circular RNA Splicing.

Nicole Eger1, Laura Schoppe1, Susanne Schuster2, Ulrich Laufs2, Jes-Niels Boeckel3.   

Abstract

Circular RNAs (circRNAs) are covalently closed single-stranded RNA molecules derived from exons by alternative mRNA splicing. Circularization of single-stranded RNA molecules was already described in 1976 for viroids in plants. Since then several additional types of circular RNAs in many species have been described such as the circular single-stranded RNA genome of the hepatitis delta virus (HDV) or circular RNAs as products or intermediates of tRNA and rRNA maturation in archaea. CircRNAs are generally formed by covalent binding of the 5' site of an upstream exon with the 3' of the same or a downstream exon. Meanwhile, two different models of circRNA biogenesis have been described, the lariat or exon skipping model and the direct backsplicing model. In the lariat model, canonical splicing occurs before backsplicing, whereas in the direct backsplicing model, the circRNA is generated first. In this chapter, we will review the formation of circular RNAs and highlight the derivation of different types of circular RNAs.

Entities:  

Keywords:  Backsplicing; Circular RNA; RNA splicing; circRNA

Mesh:

Substances:

Year:  2018        PMID: 30259356     DOI: 10.1007/978-981-13-1426-1_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  49 in total

Review 1.  Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star.

Authors:  Qun Chen; Jiajia Li; Peng Shen; Hao Yuan; Jie Yin; Wanli Ge; Wujun Wang; Guangbin Chen; Taoyue Yang; Bin Xiao; Yi Miao; Zipeng Lu; Pengfei Wu; Kuirong Jiang
Journal:  Cell Biosci       Date:  2022-06-21       Impact factor: 9.584

2.  Comprehensive circular RNA expression profiling with associated ceRNA network in orbital venous malformation.

Authors:  Jie Yu; Peiwei Chai; Yixiong Zhou; Renbing Jia; Yefei Wang
Journal:  Mol Vis       Date:  2022-05-20       Impact factor: 2.711

3.  Engineering Circularized mRNAs for the Production of Spider Silk Proteins.

Authors:  Li Liu; Pengju Wang; Dongdong Zhao; Li Zhu; Jinlei Tang; Wenchuan Leng; Junchang Su; Yan Liu; Changhao Bi; Xueli Zhang
Journal:  Appl Environ Microbiol       Date:  2022-04-06       Impact factor: 5.005

4.  CircPAG1 interacts with miR-211-5p to promote the E2F3 expression and inhibit the high glucose-induced cell apoptosis and oxidative stress in diabetic cataract.

Authors:  Dan Tao; Zeyuan Liu; Ling Wang; Chunli Li; Rongci Zhang; Ninghua Ni
Journal:  Cell Cycle       Date:  2022-02-17       Impact factor: 5.173

Review 5.  Circular RNAs: new biomarkers of chemoresistance in cancer.

Authors:  Jiaqi Wang; Yi Zhang; Lianyu Liu; Ting Yang; Jun Song
Journal:  Cancer Biol Med       Date:  2021-03-19       Impact factor: 4.248

Review 6.  Circular RNAs as Novel Regulators of β-Cell Functions under Physiological and Pathological Conditions.

Authors:  Flora Brozzi; Romano Regazzi
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 7.  Circular RNA translation, a path to hidden proteome.

Authors:  Tanvi Sinha; Chirag Panigrahi; Debojyoti Das; Amaresh Chandra Panda
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-08-02       Impact factor: 9.349

Review 8.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.

Authors:  Yicun Jiang; Leilei Zhao; Yiwen Wu; Sijun Deng; Pu Cao; Xiaoyong Lei; Xiaoyan Yang
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 9.  Circle the Cardiac Remodeling With circRNAs.

Authors:  Tiqun Yang; Tianxin Long; Tailai Du; Yili Chen; Yugang Dong; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2021-06-25

10.  CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p.

Authors:  Wei Fang; Jiao Mu; Yi Yang; Lin Liu
Journal:  J Bone Oncol       Date:  2021-07-08       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.